Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule (Q36490048)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 December 2012

Language	Label	Description	Also known as
English	Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule	scientific article published on 3 December 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

object named as

Lindsay Fraser

2

0 references

object named as

Adam N Rosenthal

1

0 references

object named as

Usha Menon

15

0 references

object named as

Diana M Eccles

12

0 references

1 reference

ORCID Public Data File 2021

Ranjit Manchanda

3

object named as

Ranjit Manchanda

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

10

object named as

Naveena Singh

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4

object named as

Philip Badman

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

5

object named as

Susan Philpott

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Jessica Mozersky

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Richard Hadwin

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Fay H Cafferty

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Elizabeth Benjamin

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Steven J Skates

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

James Mackay

14

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ian J Jacobs

16

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

3 December 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

49-57

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

describes a project that uses

1 reference

Europe PubMed Central

26 June 2022

https://europepmc.org/article/PMC/PMC3530690

based on heuristic

inferred from PubMed Central ID database lookup

Effect of Screening on Ovarian Cancer Mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

The preclinical natural history of serous ovarian cancer: defining the target for early detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Update on ovarian cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

30 September 2017

Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

28 June 2018

Screening for ovarian cancer: a pilot randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

28 June 2018

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

28 June 2018

Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Early detection of breast and ovarian cancer in families with BRCA mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Prospectively detected cancer in familial breast/ovarian cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530690

21 September 2018

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of epithelial ovarian cancer: implications for screening women at high genetic risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CA-125 antigen levels increase during menses

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of perimenopausal fractures‐a prospective population‐based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for familial ovarian cancer: the need for well-designed prospective studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23213100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.39.7638

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36490048&oldid=1744023311"